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ABSTRACT 
Background: Epilepsy is a public health issue in sub-Saharan Africa (SSA) where many people 
with the condition receive no treatment. Healthcare services for epilepsy in this region have not 
been comprehensively assessed. We examined key features of epilepsy health services 
provided in SSA. 
Methodology: This was a scoping review conducted using pre-specified protocols. We 
implemented an electronic search strategy to identify relevant citations using PUBMED, 
EMBASE, Web of Science, Scopus, Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), African Index Medicus (AIM), Open Grey, Cochrane database, and Google Scholar. 
Articles eligible for full-text review were screened and data of interest reported. 
Result: The search identified 81 eligible articles, forty-nine from East Africa, 19 from West 
Africa, 8 from South Africa, and 5 from Central Africa. A variety of care services were identified, 
with reporting of rural epilepsy care in 75% of retrieved articles mainly from East and South 
African countries. The majority of the rural epilepsy clinics were health worker- or nurse-led, 
reporting a good seizure control in about two-third of patients using phenobarbital as the most 
commonly prescribed antiepileptic drug. Funding for rural epilepsy care came mainly from 
external donor agencies.  
Conclusion: We attempted to provide a ‘snapshot’ of epilepsy care services in SSA. The 
successes achieved in some of the centres are due to the use of existing primary health care 
system and employing non-physician health-care personnel. The true picture of epilepsy care 
coverage is not apparent due to the lack of data and proper health system structure in most 
parts of SSA. As more individuals begin to receive care, the long-term funding for epilepsy care 
in African countries will depend on the commitment of their respective governments. 
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1.0 INTRODUCTION 
Epilepsy is a public health problem causing physical and psychosocial burdens on those 
affected as it interferes with educational attainment, professional goals, and social integration 
[1]. It contributes about 7 million disability adjusted life years (DALYs) to the global disease 
burden and more than 20% of the total global DALYs for neurological disorders [2], with an 
estimated 85% of this burden falling on low- and middle-income countries (LMICs) [3]. People 
with epilepsy often die prematurely [4] and despite the paucity of disease-specific data seems to 
be a major issue in sub-Saharan Africa (SSA) particularly when compared to other parts of the 
world [5, 6]. Studies from rural Kenya and South Africa reported that about three-fourths of the 
total epilepsy DALYs  were due to premature mortality [7, 8]. 
A diagnosis of epilepsy comes with enormous physical, economic, and social consequences [9, 
10]. Epilepsy is not generally perceived to be a health issue in traditional African cultures. The 
resultant lack of awareness is an important issue that limits access to health care and 
contributes to the high epilepsy treatment gap [11, 12]. Inefficient health-care systems, high 
costs of treatment, long distances, geographic difficulties, and poor transportation negatively 
impact access to treatment [13]. Even where functional health-care facilities exist, they are more 
likely to benefit the more affluent urban inhabitants than the rural poor. This inequality increases 
the complexity of managing epilepsy in resource-poor countries [14]. A multivariable analysis of 
risk factors for the treatment gap in rural Kenya reported that individuals living more than 30 km 
from health facilities were four times less likely to access health care and those who had to pay 
for antiepileptic drugs (AEDs) were three times less likely to take it [12]. It was suggested that 
public education, easy access to basic care and making AEDs freely available are essential in 
addressing the treatment gap.  
The WHO Mental Health Gap Action Programme (mhGAP) has attempted to scale-up services 
for mental, neurological, and substance-misuse disorders in LMICs. The programme asserts 
that with proper care, psychosocial assistance, and medications the majority of currently 
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underserved individuals could be treated [15]. An understanding of existing epilepsy care and 
what is obtainable in SSA will provide background information for the development of 
appropriate health policies and interventions in Africa. Our objective was to identify, extract, and 
discuss information relating to epilepsy health care services available in SSA; specifically 
focusing on the rationale and nature of services, the diagnostic facilities available, and the 
sources of funding. We also looked at hindrances to optimal healthcare and identified research 
gaps.   
2.0 METHODOLOGY 
2.1 Protocol 
The methodology employed followed the modified six-stage framework for conducting scoping 
reviews [16, 17] (Table 1).  
2.2  Identifying relevant studies/Search strategies 
An online search of PUBMED, EMBASE, Web of Science, Scopus, Cumulative Index to Nursing 
and Allied Health Literature (CINAHL), African Index Medicus (AIM), Open Grey, the Cochrane 
database and Google Scholar was conducted. Initially, an experienced librarian helped refine 
the review questions by testing several combinations using the PubMed medical subject 
headings (MeSH) and Emtree for Embase to develop the most appropriate search strategy (See 
Supplement 1 for search details). A backward search from the reference list of key publications 
and review articles was also done. Due to the peculiarity of retrieving publications from Africa, a 
search of grey literature sources like National Guidelines, the ILAE/IBE, and reports from NGOs 
was conducted by searching Google scholar. An initial study screening was made by scanning 
each search result using the title and abstract. The full texts of the selected articles were then 
read and screened for eligibility. The latest search was performed on the 30th of July 2016. 
2.3 Study selection 
All available articles reporting any form of epilepsy health service provision or intervention for 
any age group in SSA were included. These included original articles, news reports, webpages 
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of organisations, reports from international organisations/associations like the WHO, 
International League Against Epilepsy (ILAE) and International Bureau for Epilepsy (IBE). There 
were no restrictions on language, year of publication, sample size or duration. Articles such as 
single cases, case series, and articles on special sub-populations, like febrile seizures and 
cerebral malaria were excluded.   
2.4 Charting the data and summarising report 
The data of interest included epilepsy healthcare services available in SSA: focusing on the type 
and nature of epilepsy services, the diagnostic facilities available, and the sources of funding. 
The results were stratified by geographic regions and countries. 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm) stating the care recipients and 
population type (e.g. rural or urban). All the countries in SSA are either low- or middle-income 
countries (LMIC), apart from Angola, Botswana, Gabon, Namibia, and South Africa who are in 
the upper middle-income countries (http://data.worldbank.org/income-level/LMY/UMC).  
3.0 RESULTS 
3.1 Characteristics of the publications retrieved 
Eighty-one relevant journal articles, newsletters and webpages were identified (Figure 1). The 
39 services, resources available, funding sources and collaborators are summarised in Tables 2 
and 3. The distribution of care centres is shown on a map (Figure 2). Most of the programmes 
(75%) target rural or suburban populations. Even where care was based in tertiary care centres, 
they also served rural and community outposts [45, 49, 59]. Some of the rural care programmes 
recruited individuals for treatment following epidemiological surveys, community engagements 
or after recognising particular needs. 
The majority of rural care facilities were led by non-physician health workers trained and 
supervised by physicians or foreign collaborators. The AED most readily available and used 
was phenobarbital, provided free or at subsidized rate. The Nakuru project reported seizure 
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freedom in 53%, with a further 26% having significant seizure reduction in the initial six months, 
with a compliance rate of 82% [19]. The Tanzanian cohort showed that 52% were seizure free 
and 36% had reduced seizures [26]. The Malian programme reported an 80% seizure-freedom 
and an additional 16% had significant seizure reduction [72]. A similar follow-up programme in 
Mali observed that 60% of those followed-up for a year were seizure-free [75]. The Togolese 
programme reported over 90% being seizure free for over 2 years [84]. A non-physician-led 
clinic at the rural Mbangassina area of Cameroon, using management algorithm reported that 
70% went into remission, while 16% had partial improvement [90]. The programme at the 
Kabende parish in Uganda observed that about a third of subjects became seizure free [46]. 
Non-governmental organisations (NGOs) like Kenya Association for the Welfare of People with 
Epilepsy (KAWE), Hope for Humans, the Epilepsy Support Foundations, Malawi Epilepsy 
Association, and the Federation of Disability Organisations in Malawi in addition to providing 
free treatment or at cheaper rates, are involved in community engagement, counselling and 
education of patients and families, they also lobby for equal opportunities for schooling and 
income generation. These NGOs coordinate with urban healthcare facilities to form outreach 
programmes and train allied health workers to render services in rural areas using epilepsy 
protocols  
Four articles reported on experiences of epilepsy surgery conducted in South Africa [91, 92], 
Kenya [93], and Uganda [94]. Apart from CURE Children’s Hospital of Uganda (CCHU) for 
Epilepsy surgery [94] and the Red Cross War Memorial Children’s Hospital [66] all of the care 
facilities served adults and children. Almost all of these facilities are fully or partly funded by 
organisations and institutions from the US and Europe. 
4.0  DISCUSSION 
We wanted to explore the range of epilepsy services or programmes available in SSA and to 
present our perspectives on potential options to improve access to care in the continent. This 
review was undertaken as the first step towards developing a better understanding of the nature 
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and scope of the literature related to epilepsy care provision in SSA. A scoping approach was 
preferred over a systematic review as an initial method for reviewing existing health research 
evidence in order to understand the range of services available rather than the quality of 
individual studies [95]. The most notable finding is that the overwhelming majority of African 
epilepsy care services are provided through centres based in rural areas. Three reasons can 
explain why rural programmes are popular and could represent the best model to reduce the 
treatment gap in Africa. Firstly, people in rural areas particularly need assistance because they 
are economically disadvantaged and can hardly afford most AEDs and the specialised epilepsy 
services often concentrated in major urban conurbations. Secondly, programmes that are run in 
rural centres are usually integrated within existing primary health care systems and are so more 
sustainable. Thirdly, most programmes in rural areas do not need sophisticated diagnostic 
technology and non-physician health workers can easily be trained to diagnose and provide 
quality care [18, 27, 36, 72, 75, 90].  
It has recently been shown that community-based approach to providing care for chronic 
medical conditions is cost effective and sustainable [96]. With adequate training, people in allied 
medical professions can provide quality care in areas where access to physicians is limited and 
as a result, significantly reduce the treatment gap [97]. The efficiency of such community-based 
rural programs can sometimes be reinforced by the existence of a strong referral and counter-
referral system with specialist centre. In Zambia [98] and Ethiopia [44] for example, rural clinics 
were linked with tertiary hospitals for the referral of those needing specialist assessment and 
further investigations. Some have proposed a care model for a national epilepsy programme 
where 60% of individuals can be successful managed in the rural community, while 30% may be 
referred to a secondary facility, with only 10% ever reaching tertiary care [98]. Apart from 
reducing the treatment gap, it is possible that establishing a well-coordinated rural health 
programme would reduce the total cost of epilepsy care provision in SSA, although this requires 
further research. 
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Community engagement and education seem critical in improving access to care and 
compliance. A Zimbabwean study reported that educating community health workers in epilepsy 
care improved recruitment and drug compliance [54]. It was observed that educating community 
leaders was useful in improving health seeking behaviour amongst people [99]. Psychosocial 
issues associated with epilepsy have been recognised as one of the most important determining 
factors causing the high treatment gap in Africa [12]. While the myths and stigmas surrounding 
epilepsy appear to be changing in many of these rural care facilities as a result of the favourable 
outcome of treatment, providing epilepsy care to people in rural settings in Africa remains 
challenging due to the considerable knowledge gap [51, 100]. Support groups have been shown 
to be useful in dispelling social stigma, improving treatment compliance, enhancing social 
acceptance and integration [27, 53, 66]. Support groups have also been shown to improve 
psychosocial indicators such as: positive self-management, social outlook, better coping 
strategies and quality of life (QOL)[101, 102]. The work by KAWE in rural Kenya illustrated how 
community-based NGOs can coordinate with the nurse-led system to cover more of the 
population especially with regards to aspects of education and social support (http://www.kawe-
kenya.org). More studies are needed on the role of support groups and the influence of 
community education in improving public perception, social integration and the quality of life for 
people with epilepsy.  
An important observation is the role of mobile epilepsy care including home visits to provide 
drugs and support. This has been shown to be helpful in improving compliance in rural 
communities in Malawi [36], Senegal [80], Mali [72], Togo [84], and by KAWE [22, 23]. The long-
term feasibility and value of mobile care needs to be examined in larger longitudinal studies. It 
has been suggested that healthcare centres located within a convenient walking distance would 
substantially reduce out-of-pocket expenses and may be of better long-term usefulness [12, 82, 
103].  
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Phenobarbital was the cheapest and most readily available AED used in majority of rural areas. 
In the Nakuru project, phenobarbital had similar efficacy and tolerability compared to 
carbamazepine [19]. Based on the success of trials and the cost advantage of phenobarbital in 
India [104], Brazil [105], and China [106], WHO has suggested the use of phenobarbital as a 
drug of choice for treating epilepsy in resource-poor settings [107, 108]. This cost-effectiveness 
has been observed in the Malian [72] and Zambian studies [98, 109], where the overall cost of 
epilepsy management is between US$15 and US$25 per person per year, which is substantially 
less than the expenses of treating other chronic health conditions. A recent study assessing the 
expected resource needs for scaling up mental health care plans, also reported that the cost of 
epilepsy care packages is significantly lower than the cost of treating psychosis [110]. The 
renewed interest in the use of barbiturates as a cost-effective option for epilepsy treatment in 
Africa, calls for further research to verify the sources and the quality of these drugs available in 
African health facilities.  
One important aspect of treatment in SSA is adherence. A Ugandan study found that almost 
80% of people reported being adherent to AED, but only about a quarter were adherent when 
serum drug levels were checked [49]. Good adherence to AED is associated with better seizure 
control, improved job prospects, increased productivity, reduced road traffic accidents and a 
better overall QOL [111]. Studies on how to reduce the adherence gap could be an important 
future research. Even though serum drug monitoring is rarely used in Africa as cost may be a 
hindrance, its use may help reduce the adherence gap, but this is not established and needs to 
be further investigated [12, 112]. 
The majority of people with epilepsy can be diagnosed clinically without the support of 
investigations as suggested by our review. The diagnostic gap in SSA requires improvement by 
providing access to EEG and neuroimaging. The diagnostic gap, the cost, and possibly the lack 
of skilled manpower have limited the use of epilepsy surgery [113]. A few centres reported 
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performing surgery on a small subset of children with hippocampal sclerosis. A separate review 
on epilepsy surgery will be imperative to understand its utilization in Africa.  
Collaborations between epilepsy care facilities in African countries and European and North 
American countries, with regard to funding, provision of drugs, diagnostic facilities, and transfer 
of technical and intellectual skills are common. They are helpful in reducing the treatment gap, 
but are vulnerable to economic and political changes. African governments must take the 
responsibility of setting up proper primary health care services [114].  
Epilepsy care provisions are more concentrated in East and South Africa compared to West and 
Central Africa. This difference could be due to several factors: publication bias; under-reporting 
of epilepsy care programs; disproportionate exposure to research partnerships and funding from 
international donor agencies; and differences in the commitment of the local Ministries of 
Health. 
In many countries in SSA, health insurance is poorly developed and payment for health services 
is out-of-pocket, making long-term management of people with chronic conditions challenging. 
In Nigeria, the National Health Insurance Scheme (NHIS) covers only 3% of the population 
mainly living in urban areas [115]. A robust health insurance scheme to cover the basic needs of 
the rural populace of Africa will probably improve access to epilepsy care and should be a 
priority for SSA. The WHO has recommended the policy of Universal Health Coverage (UHC) 
where citizens can access health care without incurring financial hardship; this could alleviate 
the burden of epilepsy and contribute to greater equality in access to care, by reducing the out-
of-pocket expenses that exacerbate poverty [116].  
This review has limitations. Firstly, there is clearly a bias for reporting rural epilepsy care 
compared to urban care, which may reflect the rapidly growing weight of literatures reporting 
model rural care. Rural epilepsy care programmes are more likely to be publicly or 
internationally funded, and therefore more likely to be published. Secondly, we may have 
excluded information as only scientific articles and few grey literatures were retrieved. The 
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potential for researchers to be unwilling to publish unfavourable results, and the inequalities of 
SSA studies to be published in indexed journals should be recognised. Thirdly, epilepsy 
services are often provided as an adjunct to mental health services [117, 118], and may not 
have been reported. Fourthly, a stakeholders’ meeting, as recommended for most scoping 
reviews [16], was not performed, due to limited resources. Such meeting would have provided 
an avenue where information on the true situation on sites may have been further elucidated. 
We recognise that this is a challenging process in SSA, and could be a possible area for future 
research. Lastly, we acknowledge that the description of epilepsy services presented here may 
not reflect all care available in all of SSA as it is unlikely to be recorded in the literature.  
 
5.0  Conclusions 
We have provided a broad view of epilepsy care provision in SSA to inform health policy. The 
main finding highlights the usefulness of rural epilepsy care in meeting the health care needs. 
This success was attributed to using the existing primary health care system and employing 
community nurses and health workers in epilepsy care. This practice of using allied health 
workers in providing primary healthcare needs, despite the lack of modern diagnostic facilities, 
is noteworthy and could be replicated. Epilepsy care should be integrated into established 
health systems if possible and modelled after successful model care programmes [119]. 
Phenobarbital is effective in over 60% of people and remains the cheapest most readily 
available AED. We recognise the usefulness of community engagement and education in 
improving access to epilepsy care and compliance. The long-term sustainability of epilepsy care 
will ultimately lie in the hands of the government of these countries. 
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 Figure 2: Map showing health care centres for people with epilepsy in sub-Saharan Africa  
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Table 1: Epilepsy healthcare provision in sub-Saharan Africa: methodological 
framework [16]. 
Stages Framework Brief Description of Steps Taken 
Stage 1 Identifying the 
research question 
What is known about epilepsy health care provision in 
SSA? Types, nature of services, diagnostic facilities, 
funding sources and hindrances to optimal healthcare. 
Stage 2 Identifying relevant 
studies 
 
Searching databases, reference lists, hand-searching 
journals by manual page-by-page examination of entire 
content of journal references, and from websites and news 
reports of related organisations. 
Stage 3 
 
Study selection All available articles reporting any form of epilepsy health 
service provision in SSA. 
Stage 4 
 
Charting the data Reviewing information of the selected literatures, recording 
the information on the type of care programme and 
interventions. Reviewing the uniqueness, successes and 
outcomes of each programme.  
Stage 5 Collating, 
summarizing and 
reporting results 
Summarising findings and reporting results. Stratifying 
results according to geographic regions and countries, 
stating care recipients, and population type (e.g. rural or 
urban). Commenting on details of interests. 
Stage 6 Consultations with 
stakeholders 
A stakeholders meeting was not conducted, but we had 
communication with contact persons who provided 
additional information about studies included in the review.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Summary of health service provision and resources available for people with epilepsy in sub-Saharan Africa 
Country Project 
name/Location 
Author(s)/Date Populatio
n 
Type of epilepsy 
care 
Resources available Funding/support 
Nurse/ 
health-
worker-led 
Physician 
supervised 
AED 
avail
able  
EEG Neuro-
imaging 
Psycho-
social 
supports 
Kenya  
 
Nakuru ICBERG 
project, Nakuru 
district  
Feksi et al., 1991 [18];  
Feksi et al., 1991 [19]; 
Feksi, 1993 [20] 
Rural & 
Semi-
urban 
  PB, 
CBZ 
× ×  Ciba Foundation, UK 
National Society for 
Epilepsy,  
 Kilifi Health and 
Demographic 
Surveillance System 
(KHDSS) 
Scott et al., 2012 [21]  Rural  
 
  PB, 
CBZ, 
PHT, 
VPA 
   Wellcome Trust, KEMRI, 
University of Oxford 
 Kenya Association 
for the Welfare of 
People with Epilepsy 
(KAWE) 
Dekker, 1993 [22]; Dekker-
de Kiefte, 1994 [23]; ILAE, 
2012 [24] http://www.kawe-
kenya.org 
Rural & 
Urban 
  PB × ×  Netherlands Epilepsy 
Fund, personal donations 
and run by volunteers 
Tanzania The Mahenge 
Epilepsy Clinic/ 
Muhimbili epilepsy 
project 
Aall‐Jilek, 1965 [25]; Jilek-
Aall and Rwiza, 1992 [26]; 
Jilek-Aall et al., 1997 [27]   
Rwiza, 1994 [28] 
 
Rural 
 
  PB, 
PHT, 
PRI
M 
× ×  IDRC, University of British 
Columbia, EPICADEC, 
Private donations  
 Epilepsy clinic Hai 
district demographic 
surveillance system 
(DSS) 
Burton et al., 2012 [29]; 
Hunter et al., 2012 [30]  
 
Rural 
 
      Wellcome Trust, DfID 
 Haydom Lutheran 
Epilepsy Clinic 
(HLEC)  
Winkler et al., 2008 [31]; 
Winkler et al., 2009 [32]; 
Winkler et al., 2009 [33]; 
Blocher et al., 2011 [34] 
Rural 
 
      Savoy Epilepsy 
Foundation Canada, 
Centre for International 
Migration Germany 
 Tanzanian Epilepsy 
Association 
Kok, 1998 [35]; Rwiza, 
1994 [28] 
Rural & 
Urban 
      British Columbia Epilepsy 
Society 
Malawi Embangweni 
Hospital, plus other 
rural clinics for 
Watts, 1989 [36]; Watts, 
1990 [37]; Watts, 1992 [38]; 
IBE, 2014 [39]; Amos and 
Rural   PB, 
PHT 
× ×  Sue Ryder Foundation, 
non-governmental 
organisations 
treating epilepsy. 
Malawi Epilepsy 
Association (MEA), 
Federation of 
Disability 
Organisations in 
Malawi (FEDOMA) 
Wapling, 2011 [40]; (Amos 
A, Personal 
communication) 
Ethiopia Gondar NCD project, 
nurse-led epilepsy 
clinics 
Berhanu et al., 2002 [41]; 
Berhanu et al., 2009 [42]  
 
Rural   PB × × × Tropical health education 
trust, Government funded 
NCD project. 
 Amanuel Mental 
Specialized Hospital 
(AMSH), Addis Ababa 
Tegegne et al., 2015 [43] Urban 
 
  PB, 
PHT, 
CBZ, 
VPA 
 ×  Financial support from 
Gondar University  and 
AMSH 
 Jimma University 
Specialized Hospital 
(JUSH) 
Kiflie et al., 2011 [44]; 
Tsegabrhan et al., 2014 
[45] 
Urban     × 
 
 JUSH 
Uganda Rural epilepsy 
treatment at Kabende 
Parish  
Kaiser et al., 1998 [46] Rural   PB × × × Local community 
 Mulago National 
referral and teaching 
hospital in Kampala 
Kaddumukasa et al., 2013 
[47]; Nabukenya et al., 
2014 [48]; Nazziwa et al., 
2014 [49]; Settumba et al., 
2015 [50]; (Kakooza A, 
Personal communication) 
Urban   PB, 
PHT, 
CBZ 
    Ugandan Goverment, 
Belgium Technical 
Cooperation, other 
international organisations 
 Hope for Human 
(Nodding syndrome) 
http://hopeforhumans.org 
(Gazda, Suzanne, personal 
communication) 
Rural    × ×  Donations from 
individuals, Geneva 
Global 
Zimbabwe Epilepsy Support 
Foundation (ESF) 
and Murambinda 
Mission Hospital 
Mugumbate and 
Mushonga, 2013 [51];  
(Kadziti, Taurai, personal 
communication) 
www.epilepsyzimbabwe.co.
zw 
Rural 
 
  PB  ×  ESF, ILAE 
 Management of PWE 
by nurses at 
Chitungwiza and ESF 
Adamolekun et al., 1997 
[52]; Adamolekun et al., 
2000 [53]  
Rural   PB  ×  W.K. Kellog Foundation. 
 Zvimba health 
district and ESF 
Adamolekun et al., 1999 
[54]  
Rural 
 
  PB  × 
 
 ESF of Zimbabwe, ILAE 
educational grant. 
 Hwedza 
demonstration 
project  
Global Campaign Against 
Epilepsy, 2012 [55] 
Rural   PB  ×  Zimbabwe Committee of 
the Global Campaign 
Against Epilepsy, WHO, 
ILAE, and IBE 
Zambia University of 
Zambia’s Teaching 
Hospital and 
Chikankata mission 
hospital plus 
affiliated area clinics 
Birbeck, 2000 [56]; 
Atadzhanov et al., 2010 
[57]; Elafros et al., 2013 
[58]; Elafros et al., 2014 
[59]  
Urban & 
Rural 
  PB 
CBZ, 
PHT 
   NIH USA 
Rwanda Gikonko Health 
Center, Kabutare 
District Hospital, and 
Butare University 
Teaching Hospital 
Rottbeck et al., 2013 [60] Rural & 
Urban 
 
  PB, 
CBZ, 
VPA, 
PHT 
× × × German Federal Ministry 
for Economic Cooperation 
and Development via the 
ESTHER programme 
South 
Africa 
Agincourt Health and 
Demographic 
Surveillance Site 
(HDSS) 
Ngugi et al., 2013 [61]; 
Wagner et al., 2014 [62]; 
Wagner et al., 2015 [63] 
Rural & 
Suburban 
 
      Wellcome Trust, Flora 
Hewlett Foundation USA, 
NIH, INDEPTH Network, 
CSIR SA, Rockefeller 
Foundation 
 Mamre Community 
Health Project 
McQueen and Swartz, 1995 
[64]  
Rural & 
Urban  
  PB, 
CBZ, 
PHT, 
VPA 
× ×  Centre for Science 
Development, University 
of Cape Town 
 The NCD service 
Hlabisa Hospital 
Coleman et al., 1998 [65]  Rural  × PHT, 
CBZ, 
PB 
× × × Government health 
services 
 Red Cross War 
Memorial Children’s 
Hospital (RCWMCH) 
Williams et al., 2015 [66]  Urban ×      RCWMCH, Epilepsy 
South Africa Western 
Cape Branch (ESA-WCB) 
Nigeria Epilepsy clinic at 
University College 
Hospital (UCH) 
Ibadan 1950s to 
1970s.  
Dada et al., 1969 [67]; 
Osuntokun and Odeku, 
1970 [68]; Osuntokun, 1972 
[69]; Osuntokun, 1979 [70]; 
Lagunju et al., 2009 [71]; 
(Ogunniyi AO, Personal 
Rural & 
urban 
 
×  PB, 
PHT, 
CBZ, 
VPA 
 × × Government hospital. 
communication) 
Mali RARE (Re´seau 
Action-Recherche 
sur l’Epilepsie) 
program 
Nimaga et al., 2002 [72]; 
Farnarier et al., 2002 [73]; 
Genton et al., 2003 [74]; 
Bruno et al., 2012 [75]  
Rural 
 
  PB × × × Sanofi-Aventis, Sante´-
Sud, Institut Rhone-
Poulenc Rorer. 
Senegal Demonstration 
project at Pikine 
Health District 
Reynolds, 2001 [76]; Sow 
and Gueye, 2003 [77]; 
Ndoye et al., 2005 [78]; Fall 
et al., 2015 [79] 
Rural & 
Suburban 
  PB × ×  ILAE, IBE. WHO 
 Mobile epilepsy 
clinics 
Boissy, 2005 [80]; Boissy, 
2008 [81] 
Suburban 
& rural 
 ×   ×   
Gambia 
 
Demographic 
surveillance Medical 
Research Council 
Coleman et al., 2002 [82]  Rural   PB × × × Gambian government and  
General medical council 
of Gambia 
 Royal Victoria 
Hospital (RVH) 
Burton and Allen, 2003 [83]  Urban ×  CBZ, 
PB, 
PHT 
× × × Gambian Government 
Togo Batamariba project at 
the Nadoba health 
centre 
Balogou et al., 2007 [84]  Rural  × PB, 
CBZ 
 × × WHO 
 Community-based 
care for epilepsy at 
six pilot districts 
Guinhouya et al., 2010 [85] Rural    × ×  WHO/AFRO, NPMH 
supply of AEDs 
Guinea-
Bissau 
Community-based 
rehabilitation (CBR) 
at Buba 
Otte et al., 2013 [86]  Rural & 
Urban 
   × ×  CBR programme 
Cameroon Essential NCD health 
intervention project 
(ENHIP)  
Unwin et al., 1999 [87]; 
Kengne et al., 2008 [88]; 
Kengne, 2009 [89] 
Rural  × PB, 
PHT, 
CBZ 
× ×  UK Government's DfID 
Health in the Next 
Millennium' programme. 
 Epilepsy clinics 
Mbangassina area 
Dongmo et al., 2003 [90] Rural  × PB, 
CBZ, 
PHT 
× × × Efforts of medical 
personnel 
available, × not available or not sure, AED – antiepileptic drug, EEG – electroencephalography, PB – Phenobarbitone, PHT – Phenytoin, CBZ – Carbamazepine, 
VPA – Valproate, PRIM – Primidone, ICBERG – International Community-based Epilepsy Research Group, KEMRI – Kenyan Medical Research Institute,  IDRC – 
International Development Research Centre, EPICADEC – The Foundation Epilepsy Care Developing Countries, DfID – Department for International 
Development, NCD – Non-Communicable Disease, ESF – Epilepsy Support Foundation, ILAE – International League Against Epilepsy, IBE – International Bureau 
for Epilepsy, WHO – World Health Organisation, NIH – National Institutes of Health,  ESTHER – Ensemble pour une Solidarite Therapeutique Hospitaliere en 
Reseau, CSIR – Council for Scientific and Industrial Research, NPMH – National Program for Mental Health, ENHIP – Essential NCD health intervention project 
 Table 3: Epilepsy surgery experiences in sub-Saharan Africa 
Country Location Population Authors (Date) Epilepsy Surgery Diagnostic 
investigations 
available 
Funding/ 
support 
Video 
EEG 
CT MRI 
South 
Africa 
Johannesburg 
Hospital 
Urban Krynauw, 1950 
[91]  
Surgery of 12 children with epilepsy 
from Infantile hemiplegia 
 × × × 
South 
Africa 
Epilepsy surgery in 
South Africa. 
Urban  
 
Butler, 2005 [92] The review observed the outcomes of 
250 epilepsy surgery procedures for 
medically intractable seizure. 
   Various 
hospitals 
Kenya Epilepsy surgery in 
Kenya 
Urban Ruperti, 1997 [93] An account of operating on 97 cases 
with intractable epilepsy 
× × × × 
Uganda CURE Children’s 
Hospital Uganda 
(CCHU) Epilepsy 
surgery 
Urban Boling et al., 2009 
[94] 
http://www.cureint
ernational.org 
CCHU is dedicated to paediatric 
neurosurgery offering epilepsy surgery 
to children with intractable epilepsy.  
  × CURE 
International 
available, × not available or not sure, EEG – electroencephalography, CT – computerised Tomography, MRI – Magnetic Resonance Imaging,  
 
Highlights 
 Health care provision for people with epilepsy in sub-Saharan Africa. 
 The care services identified were mainly rural epilepsy care from East and South 
Africa. 
 These rural services achieved success using existing primary health care system and 
employing services of non-physician personnel. 
 Phenobarbital is the most commonly prescribed antiepileptic with seizure-freedom in 
two-third of patients. 
 Funding for rural epilepsy care came mainly from external donor agencies. 
